Clinical Trials Logo

Prognostic clinical trials

View clinical trials related to Prognostic.

Filter by:
  • None
  • Page 1

NCT ID: NCT06299215 Not yet recruiting - Pyelonephritis Clinical Trials

Factors and Prognosis of Obstructive Pyelonephritis Patients

PYELO-OBS
Start date: April 15, 2024
Phase:
Study type: Observational

Acute obstructive pyelonephritis is a condition with a high risk of complications and may require admission to the intensive care unit. Most of the available data on this condition comes from small, retrospective, single-centre series. To date, no large-scale study has examined the factors associated with the prognosis of patients admitted to intensive care for acute obstructive pyelonephritis. The aim of this study is to describe the population and prognosis of patients admitted to the intensive care unit for the management of acute obstructive pyelonephritis, and to identify factors associated with a poor prognosis in these patients.

NCT ID: NCT05501613 Completed - Critically Ill Clinical Trials

Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)

Start date: January 2015
Phase:
Study type: Observational

The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.

NCT ID: NCT04354558 Recruiting - Sars-CoV2 Clinical Trials

French Single Centre Experience of Critically Ill Patients With Covid 19

CovidAmiens20
Start date: July 1, 2020
Phase:
Study type: Observational

Since the outbreak of a syndrome of acute respiratory distress associated to a novel coronavirus 2 (SARS-Cov2) that began in China, Europe and France have to face a sanitary emergency with critically care support when the patient evolves to an acute respiratory distress (ARDS). In the context of supply shortages (ventilators, bed capacities) that countries have to deal with, data were lacking of characteristics and outcomes of patients admitted to intensive care unit (ICU). the purpose of this project is to report the epidemiology and the outcomes of a French cohort of critically ill patients with SARS-Cov2

NCT ID: NCT01249859 Completed - Prognostic Clinical Trials

Prognosis of Signet Ring Cells in Upper Digestive Neoplasms

ADCI001
Start date: March 2010
Phase: N/A
Study type: Observational

Background • A major increase in incidence of signet ring cell adenocarcinomas (ADCI) of the upper digestive tract in western countries - Discordant results in the literature concerning the prognosis value of the presence of signet ring cells. - Preliminary data suggesting (i) an advanced stage at time of diagnosis, (ii) more often in the form of carcinose, (iii) a more pejorative prognosis, (iv) a recurrence more frequent, more quickly, and more often in the form of peritoneal carcinose, (v) a chemo resistance (vi) the need for a specific therapeutic strategy compared to non-signet ring cell adenocarcinomas. Primary objective To test the hypothesis that 5-year survival rate is significantly lower in the signet ring cells (SRC) adenocarcinoma when compared to non-SRC adenocarcinoma in the upper digestive tract Secondary objectives - Impact of neoadjuvant CT on overall survival - Impact and differential diagnostic value of linitis - R0 resection rates - 3 years recurrence free survival - Overall 3 years survival - Prognostic factors - Prognostic value of the presence of a minority quota of signet ring cell - Objective response rate after medical treatment (chemotherapy, radiochemotherapy) in non-resected patients - Tolerance of (radio) chemotherapy for ADCI Methodology Intention to treat retrospective case-control multicentric study A pairing on demographic criteria (age, sex, ASA score, center) and tumor criteria (TNM stage) will be done to ensure comparability in case control study groups. Inclusion criteria All consecutive patients taken care of, for a proven histologically adenocarcinoma (ADCI and ADNCI) of the esophagus, the esogastric junction, or the stomach, in surgical or medical oncology investigator centers, will be saved in a given database. For whom the first consultation took place between January 1997 and January 2010 Exclusion criteria Histological type other than adenocarcinoma Other localization than esogastric junction, esophagus or stomach Planned study period The data will be collected over a period from January 1997 to January 2010. The objective is to complete the data collection for summer 2010.